EGATEN

This brand name is authorized in United States. It is also authorized in France.

Active ingredients

The drug EGATEN contains one active pharmaceutical ingredient (API):

1	Triclabendazole UNII 4784C8E03O - TRICLABENDAZOLE
	Triclabendazole is an anthelmintic against Fasciola species, used for the treatment of fascioliasis.
	Read more about Triclabendazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EGATEN Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02BX04	Triclabendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02B Antitrematodals → P02BX Other antitrematodal agents
Discover more medicines within P02BX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	67258794
US	FDA, National Drug Code	0078-0937